Tom Robbenhaar - Profile and Investment Details

Investor Profile

Tom Robbenhaar is a Venture Capital, Private Equity Firm based in Hoofddorp, North Holland, The Netherlands with a diverse investment portfolio that includes companies such as Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation, Breath Therapeutics, Roche Glycart, Innate PharmaInova Labs, Moximed, Nightbalance, Eargo, Inari Medical, STAT-Dx, VerzuimVitaal, Ascendis Pharma, SANIFIT, BG Medicine, Prosonix, Nyxoah, Draupnir Bio, Axonics Modulation Technologies, Levicept, Big Health, Calypso Biotech, NIZO, Chroma Therapeutics, Pieris AG, LUMICKS, Ablative Solutions, Symphogen, MTM Laboratories, Definiens, Fysius Rugexperts, Agendia, Vesper Medical, Galapagos, Lumeon, Pharmaline, Volta Medical, Amphista Therapeutics, Withings, Novicare, ProFibrix, Ablynx, Conatus Pharmaceuticals, Zetacom, BionX™ Medical Technologies, Acacia Pharma, CVRx, Lava Therapeutics, Stepping Stones Home & Care, Evotec, Vapotherm, FlowCardia, FIRE1, . Over time, Tom Robbenhaar has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Tom Robbenhaar is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Wellness, Investment Management, Apps, Life Science, Artificial Intelligence (AI), Software, Biotechnology, Podcasts, Legal Tech, Hardware, Health Diagnostics, Medical, Media and Entertainment may find it worthwhile to explore potential connections with Tom Robbenhaar, as their portfolio suggests a familiarity and interest in this area.

Understanding Tom Robbenhaar’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.